2023
Multicenter Transthyretin Cardiac Amyloidosis Study Demonstrates Differences In Phenotype And Outcomes By Race
Cavalier J, Bhattacharya P, Patolia H, Chandramouli S, Sen S, Karra R, Maurer M, Khouri M. Multicenter Transthyretin Cardiac Amyloidosis Study Demonstrates Differences In Phenotype And Outcomes By Race. Journal Of Cardiac Failure 2023, 29: 699-700. DOI: 10.1016/j.cardfail.2022.10.381.Peer-Reviewed Original ResearchATTR-CM patientsReduced ejection fractionEjection fractionBlack patientsATTR-CMHeart failureWhite patientsAdvanced stageFindings merit further researchHigher NT-proBNP levelsMid-range ejection fractionNT-proBNP levelsNYHA class INYHA class IIILow ejection fractionRetrospective multicenter analysisTransthyretin amyloid cardiomyopathyLarge academic medical centerCross-sectional studyAcademic medical centerDeceased patientsMulticenter analysisWorsened prognosisRace patientsVital status
2019
The application of appropriate use criteria for transthoracic echocardiography in a cardiac intensive care unit
Salik JR, Sen S, Picard MH, Weiner RB, Dudzinski DM. The application of appropriate use criteria for transthoracic echocardiography in a cardiac intensive care unit. Echocardiography 2019, 36: 631-638. PMID: 30969477, DOI: 10.1111/echo.14314.Peer-Reviewed Original ResearchConceptsCardiac intensive care unitCurrent appropriate use criteriaAppropriate use criteriaIntensive care unitCare unitModern cardiac intensive care unitUse criteriaQuaternary care academic medical centerUnique clinical environmentAcademic medical centerTransthoracic echocardiographyCardiac arrestUnknown etiologyMedical CenterThird investigatorCardiac structureHealthcare resourcesAUC classificationClinical casesInitial evaluationTTEFurther studiesClinical environmentInvestigatorsIndications